Addex Appoints Laurent Massuyeau as Head of Business Development

22-Apr-2008

Revolutionize your production: real-time Raman analysis for maximum efficiency

Efficient inline analysis for liquids and solids

User-friendly software for effortless Design of Experiments (DoE)

Addex Pharmaceuticals announced the appointment of Laurent Massuyeau as head of business development.

Mr. Massuyeau joins Addex from Idenix Pharmaceuticals Inc., where he was executive director of European commercial operations. He brings to Addex 7 years of big pharma business development experience as well as 10 years of sales and marketing experience.

Immediately prior to joining Addex Mr. Massuyeau was executive director of European commercial operations at Idenix Pharmaceuticals Inc. From 2004-2006 he was business unit director for Lilly, France, a division of Eli Lilly & Co., leading groups responsible for strategy, business development, alliance management, sales and marketing services as well as information technology. From 2002-2004 Mr. Massuyeau was manager corporate strategy & business development at Lilly's headquarters in Indianapolis. From 2000-2001, Mr. Massuyeau was sales manager for Lilly for the New England area in the U.S. Prior to that, beginning in 1995, he held a succession of positions in Europe for Lilly. From 1992-1995 he worked for animal health company Virbac Laboratories Ltd., managing sales in Europe and Asia. Mr. Massuyeau holds an MBA from INSEAD, graduated from Nantes Veterinary School as doctor of veterinary medicine, and holds a masters degree in biochemistry from University of Medicine Paris V.

https://www.bionity.com/en/news/80989/addex-appoints-laurent-massuyeau-as-head-of-business-development.html